• 
• 
• 
• 

FDA News and Drug Updates

November 11, 2019 — Oncology News & Updates

Nubeqa New Oral Therapy FDA Approved for Nonmetastatic Prostate Cancer

Turalio First FDA-Approved Systemic Therapy for Tenosynovial Giant-Cell Tumor

Supportive Care

What an Aging Population Means for Cancer Treatment

Saima Iqbal, Ishmam Khan

Supportive Care Updates from ASCO 2017 Highlighted at New Orleans Summer Cancer Meeting

Meg Barbor, MPH

Helping Adolescents and Young Adults Confront Mortality

Meg Barbor, MPH

View All Supportive Care Articles

Lung Cancer

Repotrectinib, an Investigational TKI, Induces Response in ROS1-Fusion–Positive NSCLC

Wayne Kuznar

Osimertinib plus Savolitinib Promising for Non–Small-Cell Lung Cancer with MET-Driven Resistance

Phoebe Starr

High Tumor Mutation Burden Predictive Biomarker for Survival in Metastatic Non–Small-Cell Lung Cancer

Phoebe Starr

View All Lung Cancer Articles

Conference Correspondent

Sexual Dysfunction After Cancer: Why Aren’t We Talking About It?

The Importance of Compassion: Perspective From a Lifelong Patient

Using a Team Approach to Tackle Opioid Abuse in Patients with Cancer

Addressing the Second Victim Phenomenon

Palliative Care Use Dismal Among Patients with Hematologic Malignancies

View All Conference Correspondent Articles

Most Popular Articles

FDA on In Vitro Diagnostics, Vaping; Cost of Novel Treatments

Web Exclusives - FDA Updates, In the News, NCCN

October 28, 2019 – Oncology News & Updates

Web Exclusives - FDA Updates, In the News, Ovarian Cancer

Nubeqa New Oral Therapy FDA Approved for Nonmetastatic Prostate Cancer

Web Exclusives - FDA Updates

Turalio First FDA-Approved Systemic Therapy for Tenosynovial Giant-Cell Tumor

Web Exclusives - FDA Updates